(NaturalNews) You've heard it before, how the pharmaceutical industry has a giant "revolving door" through which corporations and government agencies frequently exchange key employees. That reality was driven home in a huge way today when news broke that Dr. Julie Gerberding, who headed the CDC from 2002 through 2009, landed a top job with Merck, one of the largest drug companies in the world. Her job there? She's the new president of the vaccine division.

How convenient. That means the former head of the CDC was very likely cultivating a relationship with Merck all these years, and now comes the big payoff: Heading up a $5 billion division that sells cervical cancer vaccines (like Gardasil), chickenpox vaccines and of course H1N1 swine flu vaccines, too.

So what's the problem with all this? The problem is that private industry and government health offices such as the CDC or FDA should never be so cozy. When they are, it creates an environment of collusion between Big Government and Big Pharma. We've already seen this with the government-led push for swine flu vaccines that are manufactured (and sold) by drug companies like Merck.

You might even say that the CDC already functions as the marketing division of the pharmaceutical industry. It was the CDC that pushed so hard for swine flu vaccines, even amid the obvious realization that swine flu was no more dangerous than seasonal flu. To this day, the CDC still hasn't bothered to recommend vitamin D for the prevention of either seasonal flu or swine flu. It remains heavily invested in the lucrative vaccine approach -- an approach that just happens to financially benefit the very corporations that are hiring ex-CDC employees like Dr. Gerberding.

Click to read more...